Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:1413-1417
Published online before print April 20, 2006, doi: 10.1161/01.STR.0000221766.73692.0b
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/6/1413    most recent
01.STR.0000221766.73692.0bv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vermeer, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vermeer, S. E.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Stroke
*Transient Ischemic Attack
Related Collections
Right arrow Glucose intolerance
Right arrow Risk Factors for Stroke

(Stroke. 2006;37:1413.)
© 2006 American Heart Association, Inc.


Original Contributions

Impaired Glucose Tolerance Increases Stroke Risk in Nondiabetic Patients With Transient Ischemic Attack or Minor Ischemic Stroke

Sarah E. Vermeer, MD, PhD; Willemijn Sandee, MSc; Ale Algra, MD, FAHA; Peter J. Koudstaal, MD, PhD; L. Jaap Kappelle, MD, PhD; Diederik W.J. Dippel, MD, PhD on behalf of the Dutch TIA Trial Study Group

From the Department of Neurology (S.E.V., W.S., P.J.K., D.W.J.D.), Erasmus Medical Center, Rotterdam; and the Department of Neurology (A.A., L.J.K.), University Medical Center Utrecht, The Netherlands.

Correspondence to S.E. Vermeer, MD, PhD, Erasmus Medical Center, Department of Neurology, PO Box 2040, 3000 CA Rotterdam, The Netherlands. E-mail s.vermeer{at}erasmusmc.nl

Background and Purpose— Impaired glucose tolerance, an intermediate metabolic state between normal glucose and diabetes characterized by nonfasting glucose levels between 7.8 to 11.0 mmol/L, is associated with an increased stroke risk in patients with coronary heart disease. Whether impaired glucose tolerance increases the risk of stroke in patients with transient ischemic attack (TIA) or minor ischemic stroke is unknown.

Methods— In total, 3127 patients with a TIA or minor ischemic stroke participated in the Dutch TIA Trial, testing 2 different doses of aspirin and atenolol versus placebo. We estimated the risk of stroke and the risk of myocardial infarction or cardiac death in relation to baseline nonfasting glucose levels (mean 6.0, SD 2.2 mmol/L) with Cox proportional hazards regression analysis, adjusted for cardiovascular risk factors.

Results— During 2.6 years follow-up, 272 patients (9%) experienced a stroke and 200 (6%) a myocardial infarction or cardiac death. We found a J-shaped relationship between baseline nonfasting glucose levels and stroke risk. Stroke risk was nearly doubled in patients with impaired glucose tolerance (glucose 7.8 to 11.0 mmol/L) compared with those with normal glucose levels (hazard ratio [HR] 1.8, 95% CI, 1.1 to 3.0) and nearly tripled in diabetic patients (glucose ≥11.1 mmol/L; HR 2.8, 95% CI, 1.9 to 4.1). Patients with low glucose levels (<4.6 mmol/L) had a 50% increased stroke risk (HR 1.5, 95% CI, 1.0 to 2.2) compared with those with normal glucose levels. There was no association between glucose levels and risk of myocardial infarction or cardiac death.

Conclusion— Impaired glucose tolerance is an independent risk factor for future stroke in nondiabetic patients with TIA or minor ischemic stroke.


Key Words: glucose • glucose intolerance • risk • transient ischemic attack




This article has been cited by other articles:


Home page
Therapeutic Advances in Cardiovascular DiseaseHome page
J. R. Romero, J. Morris, and A. Pikula
Review: Stroke prevention: modifying risk factors
Therapeutic Advances in Cardiovascular Disease, August 1, 2008; 2(4): 287 - 303.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
C. Nielson and R. M. Fleming
Blood Glucose and Cerebrovascular Disease in Nondiabetic Patients
Angiology, November 1, 2007; 58(5): 625 - 629.
[Abstract] [PDF]


Home page
StrokeHome page
F. M. Ivey, A. S. Ryan, C. E. Hafer-Macko, A. P. Goldberg, and R. F. Macko
Treadmill Aerobic Training Improves Glucose Tolerance and Indices of Insulin Sensitivity in Disabled Stroke Survivors: A Preliminary Report
Stroke, October 1, 2007; 38(10): 2752 - 2758.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. Tsuda
Hyperinsulinemia and Membrane Microviscosity of Erythrocytes as Risk Factors for Stroke in Patients With Impaired Glucose Tolerance
Stroke, November 1, 2006; 37(11): 2657 - 2657.
[Full Text] [PDF]